When.com Web Search

  1. Ads

    related to: slow release insulin brands

Search results

  1. Results From The WOW.Com Content Network
  2. Insulin glargine - Wikipedia

    en.wikipedia.org/wiki/Insulin_glargine

    Insulin glargine sold under the brand name Lantus among others is a long-acting ... microcrystals slowly release insulin for about 24 ... resulting in a slow ...

  3. Insulin degludec - Wikipedia

    en.wikipedia.org/wiki/Insulin_degludec

    Insulin degludec has an onset of action of 30–90 minutes (similar to insulin glargine and insulin detemir). There is no peak in activity, due to the slow release into systemic circulation. The duration of action of insulin degludec is reported as being longer than 24 hours. [16] [14]

  4. Insulin analog - Wikipedia

    en.wikipedia.org/wiki/Insulin_analog

    Zinc combinations of insulin are used for slow release of basal insulin. Basal insulin support is required throughout the day representing about 50% of daily insulin requirement, [18] the insulin amount needed at mealtime makes up for the remaining 50%. Non hexameric insulins (monomeric insulins) were developed to be faster acting and to ...

  5. Walmart, Novo Nordisk Unveil Own Low-Cost Brand Insulin - AOL

    www.aol.com/news/walmart-novo-nordisk-unveil-own...

    Walmart Inc (NYSE: WMT) is launching its first-ever private label insulin analog, available exclusively at its stores. The company worked directly with manufacturer Novo Nordisk A/S (NYSE: NVO) on ...

  6. Where Can I Find Affordable Insulin? - AOL

    www.aol.com/news/where-affordable-insulin...

    The latest-generation insulins provide better control of blood sugar, with fewer side effects, than ever. Some Type 1 diabetes patients take dangerous chances by rationing insulin -- skipping or ...

  7. Depot injection - Wikipedia

    en.wikipedia.org/wiki/Depot_injection

    Insulin glargine, for example, is designed to precipitate after injection so it can be slowly absorbed by the body over a longer period than regular insulin would be. [13] Depot injections of insulins have been studied to better replicate the body's natural basal rate of insulin production, and which can be activated by light to control the ...